Extracorporeal membrane oxygenation (ECMO) is a life supporting equipment and is used for patients suffering from severe and fatal illness that restricts the normal functioning of their heart or lungs and are not able to breathe properly. In such situations, the ECMO machine substitutes the functioning of the heart and lungs by use of a pump to circulate blood through an artificial lung back into the bloodstream. People undergoing a treatment supported by an ECMO machine are cared for in a hospital’s intensive care unit (ICU). This mechanism provides heart-lung bypass support and also aids the people awaiting a heart or lung transplant. People are provided an ECMO machine support for variable time lengths depending on how their medical condition which may be for only a few hours to days and can stretch for a few weeks. The usage of an ECMO machine differs in adults and children depending on the situation. There are three types of ECMO; VA ECMO, connected to both a vein and an artery and used for both heart and lungs and VV ECMO, connected to one or more veins near the heart, and used when in lung problems only and AV ECMO, Arterio-Venous type.
COVID – 19 scenario analysis:
- The COVID-19 pandemic has emerged as a humanitarian as well as economic crisis, creating strain on the society and affecting millions of people and businesses
- Industry closures and people are asked to stay in their homes which has cause taken a huge toll in terms of money and economic growth
- Over 4 million people affected globally, with 300 thousand losing their lives due to novel coronavirus
- Healthcare organizations are already working in battle mode, preparing new plans to respond growing COVID-19 patients, right from sourcing rapid diagnosing kits to sufficient PPE kits for workers
- Due to diversion of medical field towards treating COVID-19, the funding to R&D activities related to extracorporeal membrane oxygenation has been reduced and this segment have to face negligence subsequently causing negative impact on extracorporeal membrane oxygenation market
- However, WHO guidelines suggest providing ECMO support to patients with acute respiratory distress syndrome (ARDS) related to coronavirus disease
- ECMO preparedness amidst COVID-19 pandemic is important to control high transmission rate of the virus and reduce respiratory-related mortality
Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis
Increasing number of patients suffering from cardiopulmonary disease and respiratory failure is one of the prime factors driving the ECMO market. According to the American health agency CDC, a patient dies every 37 seconds from cardiovascular disease in the U.S. In addition to this, in 2018, chronic obstructive pulmonary disease (COPD) was one of the leading causes of death in the U.S.
Federal Agency of Health Research and Quality stated that in 2014, 6,890 extracorporeal membrane oxygenation procedures were performed in U.S. As per the Extracorporeal Life Support Organization, there is rise in the number of hospitals adopting and providing ECMO services, and has reached 264 in 2019 compared from 108 in 2008. Thus, the rising adoption of ECMO machines by the hospitals and ongoing technological advancements are the driving factors for ECMO market.
Supportive initiatives by the government to spread awareness about ECMO procedures and their benefits worldwide is further pushing the market development. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) program aims at spreading awareness about COPD and its diagnosis, treatment, which favors the usage of ECMO devices. Rise in aging population along with related diseases, growing patient pool of people suffering from coronary heart disease, is surging the demand for ECMO machines. According to demographic studies, coronary heart disease has presented relation with rising age factor and is a leading causes of fatalities around the world. The United Nations stated that number of people belonging to age group 80 years and above is estimated to reach hit 426 million mark by the year 2050. These factors would definitely cause a significant positive impact on extracorporeal membrane oxygenation machines market.
However, complications associated with ECMO machines such as infections, technical failure, bleeding, and high cost of treatment may hinder the market for extracorporeal membrane oxygenation machines However, various complications associated with ECMO, such as bleeding which is the most common issue and mainly occurs due to Heparin drug. According to NCBI in 2013, about 23% of patients undergoing ECMO suffered severe bleeding. Infection is another drawback of ECMO treatment and are more prone to occur when a cannula is inserted into the blood vessels. The NCBI states that bloodstream infection was one of the most common complications occurring in around 14.4% of patients on ECMO. Technical Failures is another negatively impacting factor wherein, air inside the ECMO circuit causes up to 4% failures. These reasons can restrain the growth of ECMO market in the near future.
Increase in prevalence of cardiac diseases
Cardiovascular diseases hold the first place in cause for death globally than any other disease according to World Health Organization (WHO). In 2016, cardiac diseases caused fatality in an estimated 17.9 million people, highlighting 31% of all global deaths with majority deaths were accounted in developing economies with low- and middle- income category. This can be an opportunity for the extracorporeal membrane oxygenation market to expand into developing economies.
Cardiac diseases are increasing with rising population and changing lifestyle. According to the Centers for Disease Control, the number of deaths due to cardiac diseases in United States is more than 606,000 on yearly basis. Four out of five CVD deaths are due to heart attacks and strokes. According to the World Journal of Cardiovascular Diseases, more than 7 million deaths are due to the sudden cardiac arrest worldwide every year. This makes the extracorporeal membrane oxygenation essential in treatment of cardiac disorders. Thus, the growing cases of heart failures, heart attacks, strokes, and other heart-related conditions are facilitating the extracorporeal membrane oxygenation market growth.
Recent technological advancements to catalyze the growth
Recent developments are also catalyzing technological advancements in these life support machine systems. The development of polymethylpentene (PMP) fibre technology has fastened the development of artificial membrane attributed with low resistance and improved biocompatibility. Oxygenators, hollow pumps, heparin coated cannula and many others are extensively used for multipurpose applications in surgeries related to cardiovascular diseases. Recent developments also include smaller and compact ECMO machines attributed with improvised portability, mobility and applications in emergency situations.
These ECMO machines are light enough to be carried by one person can be transported via an ambulance or helicopters in emergency situations in remote areas. These developments would amplify the growth and create abundant opportunities for ECMO market.
Key benefits of the report:
- This study presents the analytical depiction of the global extracorporeal membrane oxygenation industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global extracorporeal membrane oxygenation market share.
- The current market is quantitatively analysed to highlight the global extracorporeal membrane oxygenation market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the extracorporeal membrane oxygenation market.
- The report provides a detailed global market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the Extracorporeal Membrane Oxygenation Market research report:
- Who are the leading market players active in the extracorporeal membrane oxygenation market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that will help in taking further strategic steps?
Extracorporeal Membrane Oxygenation Market Report Highlights
| Aspects | Details |
 By Components |
|
 By Modulation |
|
 By Application |
|
 By Region |
|
 Key Market Players | Medos Medizintechnik AG, NIPRO Corporation, XENIOS AG, LivaNova PLC, OriGen Biomedical Inc., Getinge Group, Medtronic PLC, EUROSETS S.r.l., ALung Technologies Inc., Microsoft Scientific Corporation |
Loading Table Of Content...
